RCEP背景下我国中医药出口贸易潜力研究

Research on the Potential of Traditional Chinese Medicine Export Trade in China Under the Background of RCEP

RCEP协定正式生效后,与中医药有关的贸易也随之迎来了新的发展机遇,其中最为显著的是,由于货物贸易零关税而带来的中医药出口贸易的增加。基于扩展的贸易引力模型,文章分析了国内生产总值、人口规模、人均卫生费用、各国65岁及以上人口数量等因素对中国向RCEP伙伴国出口中医药的影响。结论表明,我国与RCEP伙伴国的GDP数值越大、进口国人口越多、进口国人均卫生费用越高、65岁及以上人口越多时,越有利于我国中医药出口。同时根据测算发现我国与马来西亚、韩国和新加坡等国仍具有很大的贸易上升空间。最后,文章提出了以下建议:一是积极推进落实RCEP协定;二是加快完善中医药相关法律法规;三是重视利用RCEP协定相关规则。

After the RCEP agreement officially came into effect,trade related to traditional Chinese medicine has also ushered in new development opportunities,among which the most significant is the increase in traditional Chinese medicine export trade due to zero tariff on goods trade.Based on an extended trade gravity model,this article analyzes the impact of factors such as GDP,population size,per capita health costs,and the number of people aged 65 and above in each country on China's exports of traditional Chinese medicine to RCEP partner countries.The conclusion indicates that the larger the GDP value between China and RCEP partner countries,the more population the importing country has,the higher the per capita health expenses of the importing country,and the more population aged 65 and above,the more favorable it is for China's exports of traditional Chinese medicine.At the same time,according to calculations,it is found that there is still significant room for trade growth between China and countries such as Malaysia,South Korea and Singapore.Finally,this article proposes the following suggestions.Firstly,the state should actively promote the implementation of the RCEP agreement.Secondly,it needs to accelerate the improvement of relevant laws and regulations on traditional Chinese medicine.Thirdly,more attention should be paid to utilizing the relevant rules of the RCEP agreement.